1. Home
  2. WHG vs PLX Comparison

WHG vs PLX Comparison

Compare WHG & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$17.99

Market Cap

156.2M

Sector

Finance

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.02

Market Cap

168.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
PLX
Founded
1983
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
156.2M
168.4M
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
WHG
PLX
Price
$17.99
$2.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
15.0K
578.5K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
3.58%
N/A
EPS Growth
203.85
N/A
EPS
0.09
0.22
Revenue
$97,762,000.00
$52,744,000.00
Revenue This Year
N/A
$36.81
Revenue Next Year
N/A
N/A
P/E Ratio
$201.33
$9.36
Revenue Growth
3.21
N/A
52 Week Low
$14.70
$1.34
52 Week High
$18.99
$3.19

Technical Indicators

Market Signals
Indicator
WHG
PLX
Relative Strength Index (RSI) 67.40 45.96
Support Level $15.72 $1.95
Resistance Level $18.64 $2.17
Average True Range (ATR) 0.71 0.06
MACD 0.14 0.01
Stochastic Oscillator 81.43 30.77

Price Performance

Historical Comparison
WHG
PLX

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: